Recent News

• 09.11.2025 - KalVista 2026 FYQ1 Business Update
• 09.11.2025 - KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results
• 09.11.2025 - KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results
• 09.04.2025 - KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025
• 09.04.2025 - KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025
• 09.04.2025 - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.04.2025 - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.03.2025 - Cantor Global Healthcare Conference
• 08.27.2025 - KalVista Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2025
• 08.27.2025 - KalVista Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2025

Recent Filings

• 09.11.2025 - EX-99.1 EX-99.1
• 09.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 09.11.2025 - 8-K Current report
• 09.09.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.25.2025 - 4 Statement of changes in beneficial ownership of securities